Your browser version is outdated. We recommend that you update your browser to the latest version.

DeNovX is ...

Patents on DeNovX's Company-Owned Nucleation Surfaces Granted in Europe and Canada

Posted 9/18/2019

DeNovX has received the exciting news that its company-owned patents for improving crystallization using engineered nucleation features have been granted by the European and Canadian patent offices. These patents add to the already issued patents in the US and Japan (below), signalling broad coverage in those jurisdictions in which crystallization is an important process in the pharmaceutical, food, cosmetic, agricultural, fine chemical, and bioengineering fields that stand to benefit from these crystal nucleation technologies.